Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management - Scorecard - MDSpire
Advertisement
Life-Threatening Complications in Cancer Patients in the ICU During Immunotherapy: Identification, Differential Diagnosis, and Treatment Approaches
Clinical Scorecard: Life-Threatening Complications in Cancer Patients in the ICU During Immunotherapy: Identification, Differential Diagnosis, and Treatment Approaches
At a Glance
Category
Detail
Condition
Immunotherapy-related critical illness in cancer patients
Key Mechanisms
Cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, severe pneumonitis, myocarditis, and overlapping infectious complications
Target Population
Cancer patients receiving immunotherapy
Care Setting
Intensive Care Unit (ICU)
Key Highlights
Immunotherapy introduces unique ICU-relevant complications distinct from traditional oncology critical illness patterns.
Key complications include hyperinflammatory syndromes, neurotoxicity, severe pneumonitis, and myocarditis.
Recognition of overlapping clinical presentations is crucial for effective management.
Timely ICU escalation and integrated supportive care can improve outcomes.
A substantial proportion of complications are potentially reversible with appropriate intervention.
Guideline-Based Recommendations
Diagnosis
Utilize a syndrome-based framework for recognizing immunotherapy-related complications.
Consider differential diagnoses including sepsis, opportunistic infection, and drug-related organ dysfunction.
Management
Implement early organ support and immunomodulatory therapy.
Adopt standardized pathways for managing acute toxicities.
Monitoring & Follow-up
Conduct serial reassessments to evaluate patient status and response to treatment.
Risks
Delayed recognition and intervention may adversely affect short-term outcomes.
Patient & Prescribing Data
Patients with cancer undergoing immunotherapy, including CAR-T therapy, immune checkpoint inhibitors, and bispecific T-cell engagers.
Multidisciplinary collaboration is essential for managing complex ICU cases related to immunotherapy.
Clinical Best Practices
Prioritize early ICU admission for patients exhibiting signs of immunotherapy-related complications.
Employ a multidisciplinary approach to care, integrating various specialties for optimal management.
